FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileStablecoin Development Corp.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
SDEV
Stablecoin Development Corp. Stock AnalysisComprehensive stock analysis for Stablecoin Development Corp. (SDEV) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisSDEV
SDEV
Stablecoin Development Corp.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
SDEV
  1. Home
  2. Stocks
  3. Stablecoin Development Corp.

Stablecoin Development Corp.

🇺🇸SDEV•AMEX

Stablecoin Development Corp.

🇺🇸SDEV•AMEX
Market cap
$24.55M
P/E ratio
0.03

Your view on SDEV

Mkt Cap
$24.55M
P/E
0.03
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Stablecoin Development Corp.

Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
Michael Kazley
Headquarters
2000 Powell Street, Emeryville, CA, US
Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
Michael Kazley
Headquarters
2000 Powell Street, Emeryville, CA, US
Description

Stablecoin Development Corp. specializes in manufacturing and distributing eye and skin health solutions that have undergone rigorous scientific development and proven efficacy in clinical settings. Their product portfolio features prominent brands such as Avenova, NeutroPhase, and DERMAdoctor.

This enterprise was established on January 19, 2000, and its main office is situated in Emeryville, California.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Stablecoin Development Corp.. Starting points for Stablecoin Development Corp.: P/E 0.0, EPS $2.45, beta 0.09 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Stablecoin Development Corp.. Trailing twelve-month EPS for Stablecoin Development Corp. stands at $2.45. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 22, 2026
More →

Earnings per share estimates

Per shareThis quarterDec 2026This yearYear to Dec 2026
Average estimate$0.15−$1.90
Lowest estimate$0.15−$1.90
Highest estimate$0.15−$1.90
Number of analysts11
A year ago−$4.571−$110.311
Growth vs a year ago——

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis quarterDec 2026This yearYear to Dec 2026
Average estimate$5.20M$15.80M
Lowest estimate$5.20M$15.80M
Highest estimate$5.20M$15.80M
Number of analysts11
A year ago−$521000.00$0.00
Growth vs a year ago+1098.1%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Stablecoin Development Corp.. Stablecoin Development Corp. has reported as a listed company since 2007. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold SDEV18 companies · 2 funds
Compare SDEV with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
EYPTEyePoint Pharmaceuticals, Inc.HealthcareBiotechnology$26.6M
HROWHarrow Health, Inc.HealthcareDrug Manufacturers - Specialty & Generic$1.1B
OCGNOcugen, Inc.HealthcareBiotechnology$260.6M
OCSOculis Holding AGHealthcareBiotechnology$435.8M
SLGLSol-Gel Technologies Ltd.HealthcareBiotechnology$180.6M
TTRXTurn Therapeutics Inc.HealthcareBiotechnology$247.5M
More Medical - Pharmaceuticals companies
TickerTypeCompanySectorExchangeMkt cap
SDGCFSundrug Co.,Ltd.HealthcareOTC$3.3B
SGIPFSugi Holdings Co.,Ltd.HealthcareOTC$2.9B
SHMNSOHM, Inc.HealthcareOTC$1.9M
SKVISkinvisible, Inc.HealthcareOTC$1.1M
SNNCSibannac, Inc.HealthcareOTC$197,600
SPPHSpencer Pharmaceutical Inc.HealthcareOTC$29,436
SYDRFDelota Corp.HealthcareOTC$2.9M
SYMQYSymBio Pharmaceuticals LimitedHealthcareOTC$27.2M
TNPHTian'an Pharmaceutical Co., Ltd.HealthcareOTC$139,957
TRGMTargeted Medical Pharma, Inc.HealthcareOTC$3,019
TRXBTRex Bio Inc.HealthcareNASDAQ$85.9M
TSUSFTsuruha Holdings Inc.HealthcareOTC$4.2B
ETFs holding Stablecoin Development Corp.
TickerFundFund assets% of the fund
VXFVanguard Extended Market ETF$30.2B in assets0.00%
IWCiShares Micro-Cap ETF$1.2B in assets0.00%

Largest holders first, then the funds most concentrated in SDEV.

Open Comparable Analysis
Ownership & News

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Stablecoin Development Corp. executives and directors. Shares of Stablecoin Development Corp. have traded between $1.00 and $2.13 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Stablecoin Development Corp.. Coverage tracks Stablecoin Development Corp. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Stablecoin Development Corp.

SDEV AnalysisGood
Past
1
Growth
1
Health
5
Profit
5
Value
5